Color me bad: microbial pigments as virulence factors.
暂无分享,去创建一个
[1] S. Kjelleberg,et al. Impact of Violacein-Producing Bacteria on Survival and Feeding of Bacterivorous Nanoflagellates , 2004, Applied and Environmental Microbiology.
[2] C. Schmidt-Dannert,et al. Engineering novel carotenoids in microorganisms. , 2000, Current opinion in biotechnology.
[3] T. G. Truscott,et al. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. , 2004, Archives of biochemistry and biophysics.
[4] E. Jacobson,et al. Ferric iron reduction by Cryptococcus neoformans , 1997, Infection and immunity.
[5] B. Monks,et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 , 2007, Proceedings of the National Academy of Sciences.
[6] J. Nosanchuk,et al. Melanin and fungi , 2003, Current opinion in infectious diseases.
[7] A. Casadevall,et al. Cryptococcus neoformans Can Utilize the Bacterial Melanin Precursor Homogentisic Acid for Fungal Melanogenesis , 2006, Applied and Environmental Microbiology.
[8] S. Jackson,et al. A Melanin Pigment Purified from an Epidemic Strain of Burkholderia cepacia Attenuates Monocyte Respiratory Burst Activity by Scavenging Superoxide Anion , 1999, Infection and Immunity.
[9] D. Hassett,et al. The role of pyocyanin in Pseudomonas aeruginosa infection. , 2004, Trends in molecular medicine.
[10] K. Poralla,et al. Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus , 1994, Journal of bacteriology.
[11] D. Spitz,et al. Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[12] D. Hassett,et al. Human targets of Pseudomonas aeruginosa pyocyanin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Garger,et al. Synthetic melanin suppresses production of proinflammatory cytokines. , 2000, Cellular immunology.
[14] S. Baron,et al. Antibiotic action of pyocyanin , 1981, Antimicrobial Agents and Chemotherapy.
[15] C. Rausch,et al. Microevolution of Cytochrome bd Oxidase in Staphylococci and Its Implication in Resistance to Respiratory Toxins Released by Pseudomonas , 2006, Journal of Bacteriology.
[16] J. M. Cuerva,et al. Granadaene: Proposed Structure of the Group B Streptococcus Polyenic Pigment , 2006, Applied and Environmental Microbiology.
[17] Richard B. Johnston,et al. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.
[18] A. Kourounakis,et al. Anti-inflammatory and immunomodulating properties of grape melanin. Inhibitory effects on paw edema and adjuvant induced disease. , 1998, Arzneimittel-Forschung.
[19] G. Denning,et al. Pseudomonas pyocyanine alters calcium signaling in human airway epithelial cells. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[20] S. Gribaldo,et al. Study of a melanic pigment of Proteus mirabilis. , 1996, Research in microbiology.
[21] T. Egan,et al. Haemozoin formation. , 2008, Molecular and biochemical parasitology.
[22] V. Nizet,et al. Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] V. Nizet,et al. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. , 2008, Science.
[24] H. Forman,et al. Redox signaling in macrophages. , 2001, Molecular aspects of medicine.
[25] M. Wheeler,et al. Biosynthesis and Functions of Melanin inSporothrix schenckii , 2000, Infection and Immunity.
[26] S. Bhakdi,et al. Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence , 1997, Infection and immunity.
[27] D. Hassett,et al. Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vaculoar ATPase‐dependent cystic fibrosis transmembrane conductance regulator expression and localization , 2006, Cellular microbiology.
[28] A. Carvalho,et al. [Chronic granulomatous disease]. , 1973, AMB : revista da Associacao Medica Brasileira.
[29] J. Smalley,et al. The periodontopathogen Porphyromonas gingivalis binds iron protoporphyrin IX in the mu-oxo dimeric form: an oxidative buffer and possible pathogenic mechanism. , 1998, The Biochemical journal.
[30] J. Curtis,et al. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. , 1995, Journal of immunology.
[31] A. Casadevall,et al. Melanization of Cryptococcus neoformans and Histoplasma capsulatum Reduces Their Susceptibilities to Amphotericin B and Caspofungin , 2002, Antimicrobial Agents and Chemotherapy.
[32] V. Choubey,et al. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. , 2007, Life sciences.
[33] C. Nathan. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. , 2003, The Journal of clinical investigation.
[34] A. Casadevall,et al. Passive Immunization with Melanin-Binding Monoclonal Antibodies Prolongs Survival of Mice with Lethal Cryptococcus neoformans Infection , 2001, Infection and Immunity.
[35] N. Durán,et al. Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells. , 2006, Carcinogenesis.
[36] D. Hassett,et al. Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice , 2004, Infection and Immunity.
[37] K. Tracey,et al. Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo. , 1995, Journal of inflammation.
[38] V. Soto-Cerrato,et al. The prodigiosins, proapoptotic drugs with anticancer properties. , 2003, Biochemical pharmacology.
[39] V. Choubey,et al. Antimalarial drugs inhibiting hemozoin (β-hematin) formation: A mechanistic update , 2007 .
[40] R. Tompkins,et al. The Drosophila melanogaster Toll Pathway Participates in Resistance to Infection by the Gram-Negative Human Pathogen Pseudomonas aeruginosa , 2003, Infection and Immunity.
[41] B. Moore,et al. Exploiting marine actinomycete biosynthetic pathways for drug discovery , 2004, Antonie van Leeuwenhoek.
[42] A. Casadevall,et al. The antibody response to fungal melanin in mice. , 1998, Journal of immunology.
[43] G. Denning,et al. The Pseudomonas secretory product pyocyanin inhibits catalase activity in human lung epithelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[44] B. Spellerberg,et al. The cyl genes of Streptococcus agalactiae are involved in the production of pigment. , 2000, FEMS microbiology letters.
[45] A. Casadevall,et al. Melanization of Cryptococcus neoformans Affects Lung Inflammatory Responses during Cryptococcal Infection , 2005, Infection and Immunity.
[46] G. Taylor,et al. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium , 1988, Infection and immunity.
[47] D. Look,et al. Pyocyanin and Its Precursor Phenazine-1-Carboxylic Acid Increase IL-8 and Intercellular Adhesion Molecule-1 Expression in Human Airway Epithelial Cells by Oxidant-Dependent Mechanisms1 , 2005, The Journal of Immunology.
[48] B. Commoner,et al. Free Radicals in Biological Materials , 1954, Nature.
[49] P. Arese,et al. Phagocytosis of the Malarial Pigment, Hemozoin, Impairs Expression of Major Histocompatibility Complex Class II Antigen, CD54, and CD11c in Human Monocytes , 1998, Infection and Immunity.
[50] L. Stoll,et al. Pseudomonas Pyocyanin Increases Interleukin-8 Expression by Human Airway Epithelial Cells , 1998, Infection and Immunity.
[51] C. Coban,et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin , 2005, The Journal of experimental medicine.
[52] Frederick M. Ausubel,et al. Molecular Mechanisms of Bacterial Virulence Elucidated Using a Pseudomonas Aeruginosa– Caenorhabditis Elegans Pathogenesis Model , 2022 .
[53] R. Wilson,et al. Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro , 1993, Infection and immunity.
[54] H. Ginsburg,et al. Impairment of Macrophage Functions after Ingestion of Plasmodium s Erythrocytes or Isolated Malarial Pigment , 2003 .
[55] G. Taylor,et al. Induction of Neutrophil Apoptosis by the Pseudomonas aeruginosa Exotoxin Pyocyanin: A Potential Mechanism of Persistent Infection1 , 2002, The Journal of Immunology.
[56] J. Smalley,et al. The haem pigment of the oral anaerobes Prevotella nigrescens and Prevotella intermedia is composed of iron(III) protoporphyrin IX in the monomeric form. , 2003, Microbiology.
[57] Y. Jeon,et al. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis. , 2001, The Journal of pharmacology and experimental therapeutics.
[58] D. Bryant,et al. Chlorophyll biosynthesis in bacteria: the origins of structural and functional diversity. , 2007, Annual review of microbiology.
[59] V. Nizet. Streptococcal β-hemolysins: genetics and role in disease pathogenesis , 2002 .
[60] T. Vieira,et al. Antioxidant properties of violacein: possible relation on its biological function. , 2006, Bioorganic & medicinal chemistry.
[61] A. Casadevall,et al. Effects of disrupting the polyketide synthase gene WdPKS1 in Wangiella [Exophiala] dermatitidis on melanin production and resistance to killing by antifungal compounds, enzymatic degradation, and extremes in temperature , 2006, BMC Microbiology.
[62] Nelson Durán,et al. Molecular mechanism of violacein-mediated human leukemia cell death. , 2004, Blood.
[63] M. Hauser,et al. Molecular Cloning and Characterization ofWdPKS1, a Gene Involved in Dihydroxynaphthalene Melanin Biosynthesis and Virulence in Wangiella(Exophiala) dermatitidis , 2001, Infection and Immunity.
[64] V. Nizet,et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity , 2005, The Journal of experimental medicine.
[65] N. Cianciotto,et al. The Secreted Pyomelanin Pigment of Legionella pneumophila Confers Ferric Reductase Activity , 2007, Infection and Immunity.
[66] E. Jacobson. Pathogenic roles for fungal melanins. , 2000, Clinical microbiology reviews.
[67] J. Tapsall. Pigment production by Lancefield-group-B streptococci (Streptococcus agalactiae). , 1986, Journal of medical microbiology.
[68] Nicholas J. Jacobs,et al. Characterization and incidence of pigment production by human clinical group B streptococci , 1978, Journal of clinical microbiology.
[69] N Durán,et al. Antileishmanial activity of the violacein extracted from Chromobacterium violaceum. , 2001, The Journal of antimicrobial chemotherapy.
[70] K. Kwon-Chung,et al. The Developmentally Regulated alb1 Gene ofAspergillus fumigatus: Its Role in Modulation of Conidial Morphology and Virulence , 1998, Journal of bacteriology.
[71] F. Bistoni,et al. Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neoformans strain , 2000, Journal of Neuroimmunology.
[72] F. Götz,et al. Structure and Biosynthesis of Staphyloxanthin from Staphylococcus aureus* , 2005, Journal of Biological Chemistry.
[73] A. Peschel,et al. Staphyloxanthin Plays a Role in the Fitness of Staphylococcus aureus and Its Ability To Cope with Oxidative Stress , 2006, Infection and Immunity.
[74] M. Danilenko,et al. Carotenoids and transcription. , 2004, Archives of biochemistry and biophysics.
[75] Daniel G. Lee,et al. Pyocyanin Production by Pseudomonas aeruginosa Induces Neutrophil Apoptosis and Impairs Neutrophil-Mediated Host Defenses In Vivo1 , 2005, The Journal of Immunology.
[76] A. Casadevall,et al. Impact of Melanin on Microbial Virulence and Clinical Resistance to Antimicrobial Compounds , 2006, Antimicrobial Agents and Chemotherapy.
[77] N Durán,et al. Chromobacterium violaceum: A Review of Pharmacological and Industiral Perspectives , 2001, Critical reviews in microbiology.
[78] D. Sullivan. Theories on malarial pigment formation and quinoline action. , 2002, International journal for parasitology.
[79] W. K. Roberts,et al. Melanin as a potential cryptococcal defence against microbicidal proteins. , 1999, Medical mycology.
[80] I. Polacheck,et al. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice , 1982, Journal of bacteriology.
[81] A. Casadevall,et al. Virulence: Mechanism of Action. Cryptococcus Neoformans Melanin And , 1995 .
[82] P. J. Szaniszlo,et al. Melanized and non‐melanized multicellular form mutants of Wangiella dermatitidis in mice: mortality and histopathology studies , 1992, Mycoses.
[83] J. Marshall,et al. Cytotoxic effects of violacein in human uveal melanoma cell lines , 2004, Melanoma research.
[84] O. Skorokhod,et al. Hemozoin (Malarial Pigment) Inhibits Differentiation and Maturation of Human Monocyte-Derived Dendritic Cells: A Peroxisome Proliferator-Activated Receptor-γ-Mediated Effect1 , 2004, The Journal of Immunology.
[85] J. Perfect,et al. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans , 1996, The Journal of experimental medicine.
[86] K. Kwon-Chung,et al. Aspergillus fumigatus arp1 modulates conidial pigmentation and complement deposition , 1997, Molecular microbiology.
[87] A. Casadevall,et al. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection. , 2001, The Journal of infectious diseases.
[88] Finian J. Leeper,et al. The biosynthesis and regulation of bacterial prodiginines , 2006, Nature Reviews Microbiology.
[89] W. Merz,et al. Two rapid pigmentation tests for identification of Cryptococcus neoformans , 1982, Journal of clinical microbiology.
[90] Christopher T Walsh,et al. In vitro biosynthesis of violacein from L-tryptophan by the enzymes VioA-E from Chromobacterium violaceum. , 2006, Biochemistry.